Parkinson's Aggravated by Nanoplastics Exposure
Mouse study suggests environmental nanoplastics may exacerbate Parkinson's disease through metabolic dysregulation in the gut, brain, and liver
In a recent study published in npj Parkinson’s Disease, researchers investigated the effects of chronic polystyrene nanoplastic exposure in an A53T α-synuclein mouse model. Mice were fed nanoplastics every other day for three months, revealing significant changes in gut health, including decreased mucus-producing cells and increased cell death in the gut lining, regardless of genetic predisposition. The gut microbiota also shifted, potentially increasing harmful bacteria linked to α-synuclein aggregation. Additionally, metabolic profiling showed over 200 altered metabolites, with implications for liver inflammation and neuroinflammatory markers detected in the brain.
- Chronic polystyrene nanoplastics exposure was studied in A53T α-synuclein mice.- Significant gastrointestinal changes included fewer mucus-producing cells and increased gut lining cell death.- Altered gut microbiota showed an increase in Desulfovibrio bacteria.- Metabolomic profiling revealed over 200 altered metabolites linked to inflammatory processes.- Liver inflammation was noted, but cell death levels remained unchanged.- Elevated inflammatory markers were detected in the brain tissue.